Skip to main content
Year archive

Fresenius SE & Co. KGaA — 2022 filings

All 36 regulatory filings released by Fresenius SE & Co. KGaA (FRE) in 2022, sourced directly from the official regulator.

36 Filings
2022 Period
2022 filings (36)
Filing Released Lang
Entsprechenserklärung der Fresenius SE & Co. KGaA vom 20. Dezember 2022
Governance Information
2022-12-20 German
Declaration of Conformity of Fresenius SE & Co. KGaA as of December 20, 2022
Governance Information
2022-12-20 English
Helen Giza is the new CEO of Fresenius Medical Care; Dr. Carla Kriwet leaves the company
Board/Management Information
2022-12-05 English
Report Publication Announcement 2022
Report Publication Announcement
2022-11-21 English
Fresenius SE & Co. KGaA: Dr. Francesco De Meo, buy
Director's Dealing
2022-11-18 English
Conference Call Q3 Results 2022, Fresenius
Investor Presentation Q3 2022
2022-11-03 English
Q3 statement / Q3 financial report 2022
Interim / Quarterly Report Q3 2022
2022-11-03 German
Challenging macroeconomic environment impact Fresenius Medical Care and Fresenius Group earnings in FY/22; Fresenius SE & Co. KGaA Group guidance revised
Regulatory Filings
2022-10-30 English
Morgan Stanley 20th Annual Global Healthcare Conference
Investor Presentation
2022-09-13 English
Goldman Sachs 19th Annual European Medtech and Healthcare Services Conference
Investor Presentation
2022-09-07 English
Commerzbank and ODDO BHF’s Annual Corporate Conference
Investor Presentation
2022-09-06 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing
2022-08-29 English
Fresenius SE & Co. KGaA: Michael Sen to succeed Stephan Sturm as CEO of Fresenius
Board/Management Information
2022-08-19 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing
2022-08-05 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing
2022-08-05 English
Half-yearly financial report 2022
Interim / Quarterly Report H1 2022
2022-08-04 German
Conference Call Q2 Results 2022, Fresenius
Investor Presentation
2022-07-28 English
Fresenius SE & Co. KGaA: Significantly worsening headwinds at Fresenius Medical Care impact Group net income in FY/22; Fresenius SE & Co. KGaA Group guidance revised
Earnings Release Q2 2022
2022-07-27 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing
2022-06-10 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing
2022-06-10 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2022-06-09 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing
2022-05-20 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing
2022-05-19 English
Q1 statement / Q1 financial report 2022
Interim / Quarterly Report Q1 2022
2022-05-06 English
Conference Call Q1 Results 2022, Fresenius
Call Transcript
2022-05-04 English
Erklärung zur Unternehmensführung und Corporate Governance Bericht 2021 der Fresenius SE & Co. KGaA
Governance Information
2022-05-01 German
Corporate Governance Declaration and Report 2021 of Fresenius SE & Co. KGaA
Governance Information
2022-05-01 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing
2022-04-04 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing
2022-04-04 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing
2022-04-04 English
Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting on May 13, 2022 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
AGM Information
2022-03-30 English
Annual financial report 2021
Annual Report FY 2021
2022-03-24 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing
2022-02-25 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing
2022-02-24 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-02-22 English
Conference Call FY 2021, Fresenius
Investor Presentation
2022-02-22 English